In scrapie infection of sheep and chronic wasting disease infection of cervids, prion agent infection and replication in the gut-associated lymphoreticular system (LRS) precede entry into the nervous system following oral prion exposure (1, 15, 29, 35) . After infection of the LRS, the prion agent enters peripheral nerves and retrogradely spreads to the central nervous system, where it can replicate to high levels. The scrapie agent also retrogradely spreads from the enteric nervous system to the dorsal motor nucleus of the vagus in the brainstem via the vagus nerve (21, 28, 36) . These modes of neuroinvasion are postulated to be dependent on prior agent amplification in the LRS. This is supported by studies using mice that are not susceptible to prion infection via extraneural routes of inoculation as a result of a permanent or transient loss of functional germinal centers in lymphoid follicles (17) (18) (19) (20) 22) .
However, in bovine spongiform encephalopathy (BSE)-infected cattle and atypical scrapie, the role of the LRS in prion neuroinvasion is less clear, and perhaps not essential. In natural cases of BSE, prion infectivity has not been detected in lymph nodes or spleen, and the disease-specific isoform of the prion protein PrP Sc was not found in the distal ileum (31) . Following experimental oral exposure of calves to the BSE agent, BSE infectivity was found in the distal ileum and in a single sample of tonsil but not in the spleen or lymph nodes (13, 30, 37, 38) . The paucity of the BSE agent in the LRS suggests that there may be alternative routes of prion neuroinvasion that could involve direct infection of the nervous system.
In atypical cases of scrapie the distribution of the scrapie agent in the LRS and brain is different from that found in classical scrapie. PrP Sc has not been found in lymph nodes from sheep with atypical scrapie (6) and there is a notable absence of PrP Sc immunostaining in the dorsal motor nucleus of the vagus in the brainstem (6, 10, 25) , which suggests that scrapie agent neuroinvasion does not occur via the vagus nerve. These findings raise the possibility that scrapie infection was not established via agent entry into the gut and, importantly, that infection of the LRS is not necessary for prion neuroinvasion in a subset of prion diseases.
To investigate the role of LRS infection in prion neuroinvasion, we used an experimental model of transmissible mink encephalopathy (TME) in hamsters. We tested the hypothesis that LRS-independent neuroinvasion could occur following inoculation of a densely innervated peripheral tissue, such as the tongue. Previous studies have demonstrated that intratongue inoculation of the HY strain of the TME agent resulted in rapid disease onset consistent with TME agent neuroinvasion via the hypoglossal nerve (4). We examined the ability of the DY TME agent, which does not replicate in the spleen (3), to establish TME infection following several extraneural routes of inoculation. Following intraperitoneal, intra-lymph node, or oral exposure to the DY TME agent, hamsters did not develop clinical disease and neither DY TME agent infectivity nor PrP Sc was detected in the LRS. In contrast, intratongue inoculation of hamsters with the DY TME agent resulted in prion disease in the absence of LRS infection. The initial sites of DY TME agent deposition in the brainstem following intratongue inoculation were consistent with prion neuroinvasion via the tongue-associated cranial nerves. This study suggests that neuroinvasion from highly innervated peripheral tissues does not require LRS infection and has clinical implications for a subset of prion diseases in livestock in which prion replication in the LRS is either greatly restricted or not apparent.
MATERIALS AND METHODS
Animal inoculations and tissue collection. All procedures involving animals were approved by the Institutional Animal Care and Use Committee and comply with the Guide for the Care and Use of Laboratory Animals (24) . Weanling (4 to 5 weeks old) outbred male Golden Syrian hamsters (Harlan Sprague Dawley, IN) were inoculated with a 1% (wt/vol) brain homogenate from an HY TME-or DY TME agent-infected hamster containing 10 7.5 or 10 5.4 median lethal doses per ml, respectively. Hamsters were inoculated by the intracerebral (25 l), intraperitoneal (100 l), or intratongue (20 l) route. Animals were observed three times per week for the onset of neurological disease as previously described (8) . Animals were sacrificed by CO 2 asphyxiation and tissues were removed and frozen for Western blot analysis, or the animals were perfused with fixative and the brainstem was prepared for PrP Sc immunohistochemistry. Hamster bioassay for DY TME agent infectivity. Tissues (i.e., lymph nodes, spleen, and brain) were aseptically collected from hamsters at various time points following mock inoculation or intraperitoneal (i.p.) inoculation with the DY TME agent. The tissues were minced with disposable razor blades and sterile saline was added to a final volume of 250 l. The tissue was homogenized using a 26-gauge needle prior to sonication in a cup horn sonicator (Fisher Scientific, Atlanta, GA Enrichment for PrP Sc from brain, tongue, spleen, and lymph nodes was performed as previously described (3) (4) (5) . SDS-PAGE and Western blot were performed as previously described using monoclonal anti-PrP antibody 3F4 hybridoma supernatant at a 1:10,000 dilution (23) (gift of V. Lawson, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, Hamilton, MT) (16) .
Immunohistochemistry. Immunostaining for PrP Sc in brainstem was performed as previously described (4, 23) . Briefly, animals were intracardially perfused with paraformaldehyde-lysine-periodate fixative followed by postfixation in paraformaldehyde-lysine-periodate fixative for 5 to 7 h. Paraffin-embedded tissue sections (5 m) were subjected to antigen retrieval by treatment with formic acid for 20 min, followed by a streptavidin-biotin blocking step. PrP Sc was detected by successive incubation with monoclonal 3F4 hybridoma supernatant, horse antimouse immunoglobulin G biotin conjugate (Vector Laboratories, Burlingame, CA), and streptavidin conjugated to horseradish peroxidase (Biosource, San Diego, CA). Visualization of PrP Sc staining was performed using 3-amino-9-ethylcarbazole (0.5 mg per ml) in 100 mM sodium acetate (pH 5.0) and 0.01% H 2 O 2 . Tissue was counterstained with hematoxylin. A minimum of three animals per group and 15 tissue sections per animal were examined with a Nikon E600 microscope for each antibody staining procedure.
RESULTS
Pathogenicity of the HY and DY TME agents by neural and extraneural routes of inoculation. To investigate the role of the LRS in prion neuroinvasion, hamsters were initially inoculated into the peripheral or central nervous system by the intrasciatic nerve and intracerebral routes, respectively, with the HY and DY TME agents ( Table 1 ). All neural inoculation groups were susceptible to prion disease, with the HY TME agent-inoculated groups having a shorter incubation period than the DY TME agent-inoculated hamsters, as reported previously (5, 7). The HY and DY TME agents were also inoculated into hamsters by several extraneural routes, including intraperitoneal (i.p.), intratongue, intra-lymph node, and per os. Animal groups inoculated with the HY TME agent all developed clinical disease, with the intratongue route (79 Ϯ 2 days) having the shortest incubation period and the intralymph node route the longest incubation period (190 Ϯ 20 days) ( Table 1) . However, inoculation of the DY TME agent by these peripheral routes only produced disease in the intratongue group at 262 Ϯ 7 days postinoculation. At 475 to 600 days postinoculation, clinical signs of DY TME were not observed in the i.p., intra-lymph node, and per os groups (Table  1 ). These findings suggest that DY TME agent neuroinvasion is either delayed or absent following peripheral inoculation with the exception of the intratongue inoculation group.
Since prion agent infection or disease is typically observed following i.p. inoculation in rodent models of prion disease, we tested the hypothesis that DY TME agent neuroinvasion is blocked due to the inability of the DY TME agent to either replicate in the LRS or spread from the LRS to the peripheral nervous system. In a previous study DY TME agent infectivity was not found in the spleen, sympathetic chain, or brain following i.p. inoculation (3) .
To investigate whether the lymph nodes are a potential site of DY TME agent replication, the medial iliac and mesenteric lymph nodes as well as the spleen were collected from hamsters at 60 and 120 days after i.p. inoculation with the DY TME agent. TME agent infectivity in these tissues was subsequently measured by hamster bioassay. Lymph node and spleen homogenates from one mock-infected and two DY TME agentinfected hamsters at each of the collection times postinoculation were intracerebrally inoculated into hamsters. At 400 days postinoculation none of the hamsters developed clinical symp- toms of disease (Table 2) . A control hamster group was intracerebrally inoculated with a brain homogenate containing a low dose of the DY TME agent (e.g., 10 2.2 median lethal doses) and they developed clinical disease at 204 Ϯ 1 day postinfection. These findings indicate that the DY TME agent does not replicate in the lymph nodes or spleen during the first 120 days following i.p. inoculation. Therefore, we propose that prion neuroinvasion does not occur following peripheral inoculation as a result of the inability of the DY TME agent to establish infection in the LRS.
The accumulation of the HY and DY TME agents in the brain, LRS, and tongue of TME agent-infected hamsters at clinical disease was investigated by PrP Sc Western blot in order to determine the sites of TME agent infection. Following intracerebral and i.p. inoculation of the HY TME agent, PrP Sc was found in the brain, submandibular lymph node, and spleen of clinically ill hamsters (Fig. 1) . For the DY TME agent, PrP Sc was found in the brain following intracerebral inoculation but was not detected in the spleen or submandibular lymph nodes at the time of clinical disease. Following i.p. inoculation of the DY TME agent, PrP Sc was not found in the brain, spleen, or submandibular lymph node in clinically normal hamsters at 500 days postinfection (Fig. 1) , which was consistent with the absence of TME agent infectivity in lymph nodes or spleen (Table 2). Following intratongue inoculation of the HY and DY TME agents, PrP Sc was found in both the brain and tongue at clinical disease, but PrP Sc was only detected in the lymph nodes from HY TME agent-inoculated hamsters (Fig. 2) . DY PrP Sc was absent from the spleen and the submandibular, cervical, and medial iliac lymph nodes from hamsters that developed clinical signs of DY TME following intratongue inoculation, even though up to 10-fold more lymph node tissue was analyzed compared to HY TME agent-infected hamsters. These findings indicate that DY PrP Sc does not accumulate in the lymph nodes and spleen, and this result is in agreement with the bioassay data (Table 2) , which indicate a lack of DY TME agent infectivity in these tissues. Based on these studies, we propose that prion neuroinvasion via the tongue does not require prior agent infection in the LRS. PrP Sc distribution in the nervous system following intratongue inoculation of the TME agent. The initial sites of PrP Sc deposition in the central nervous system following intratongue inoculation of the HY and DY TME agents were investigated by PrP Sc immunohistochemistry in order to determine the primary route of TME agent neuroinvasion. As previously described, intratongue inoculation of the HY TME agent resulted in detection of PrP Sc in the hypoglossal nucleus at 2 weeks postinfection (4). In the current study there was a progressive increase in the amount of HY PrP Sc deposition in the hypoglossal nucleus following intratongue inoculation of the HY TME agent, and PrP Sc was found within the cytoplasm of the hypoglossal motor neurons early after brainstem infection (Fig. 3B) . As TME agent infection progressed, the cytoplasm became progressively filled with large PrP Sc aggregates. At later time points postinfection, PrP
Sc deposits were present in the nucleus of the solitary tract and portions of the reticular formation, as previously described (4) . Neurons in these locations are known to synapse with the motor neurons in the hypoglossal nucleus, and infection of these second-order neurons is consistent with trans-synaptic spread of the HY TME agent.
Following intratongue inoculation of the DY TME agent,
FIG. 1. Tissue distribution of PrP
Sc following inoculation of TME agents by neural and extraneural routes. Hamsters were inoculated with the HY TME or DY TME agent by either the intracerebral or intraperitoneal route. Hamsters were sacrificed after the onset of clinical disease and from clinically normal, aged DY TME agent-inoculated hamsters at greater than 500 days after intraperitoneal inoculation. The brain (Br), spleen (Sp), and submandibular lymph nodes (Sm) were collected for PrP Sc analysis. Brain homogenates, containing 0.15 to 0.25 mg equivalents of tissue, and PrP Sc -enriched preparations from the spleen and lymph nodes (25 mg equivalents) were prepared as described in the text and analyzed by SDS-PAGE and PrP Western blot. The positions of molecular mass markers are indicated to the left of the panel in kilodaltons.
FIG. 2. Tissue distribution of PrP
Sc following intratongue inoculation of the HY TME and DY TME agents. Hamsters were inoculated in the tongue and sacrificed after the onset of clinical symptoms. The brain (Br), tongue (To), spleen (Sp), submandibular lymph node (Sm), cervical lymph node (Ce), and medial iliac lymph node (Mi) were collected and prepared for PrP Sc analysis and Western blot as described for Fig. 1 . Tissue amounts are indicated in milligram equivalents (Mg eq). Mock 1 60 Ͼ400 (0/4) b Ͼ400 (0/4) Ͼ400 (0/4) DY TME 1 60 Ͼ400 (0/4) Ͼ400 (0/4) Ͼ400 (0/4) DY TME 2 60 Ͼ400 (0/4) Ͼ400 (0/4) Ͼ400 (0/4) Mock 2 120 Ͼ400 (0/4) Ͼ400 (0/4) Ͼ400 (0/4) DY TME 3 120 Ͼ400 (0/4) Ͼ400 (0/4) Ͼ400 (0/4) DY TME 4 120 Ͼ400 (0/4) Ͼ400 (0/4) Ͼ400 (0/4) a Hamsters were intraperitoneally inoculated with 10 4.4 median lethal doses of the DY TME agent or a normal brain homogenate (mock). The spleen and lymph nodes (LN) were collected from two mock-inoculated and four DY TME agent-inoculated hamsters at the indicated times postinoculation for animal bioassay.
b Number affected/number inoculated.
PrP
Sc was first detected in the hypoglossal nucleus at 12 weeks postinfection; there was also evidence for PrP Sc deposition in the nucleus of the solitary tract and reticular formation at this time point. This initial distribution of DY PrP Sc in the brainstem following intratongue inoculation was similar to that for the HY TME agent except that there was no obvious delay in PrP Sc deposition in the nucleus of the solitary tract after deposition in the hypoglossal nucleus. PrP Sc deposits were not found in the brainstem at 8 weeks following intratongue inoculation of the DY TME agent; time points between 8 and 12 weeks were not examined.
The most striking difference in the hypoglossal nucleus between the HY and DY TME agent strains was the pattern of immunoreactivity. In both early and late DY TME agent infection of the hypoglossal nucleus, PrP Sc deposition was primarily found in the neuropil or associated with glia, but PrP Sc deposits were infrequently observed in the cytoplasm of motor neurons (Fig. 3C) . These deposits had a punctate staining pattern, but large PrP Sc aggregates in the somata were not found in DY TME agent infection, unlike HY TME agent infection. PrP Sc was not found in the spinal cord of either the HY TME or DY TME agent-infected hamsters at the time of initial PrP Sc detection in the brainstem for each TME agent (data not shown). This PrP Sc distribution in the nervous system was consistent with retrograde spread of the HY TME and DY TME agents along the axons of the hypoglossal nerve to the hypoglossal nucleus. In addition, for the DY TME agent, we cannot exclude a role for spread along the axons of the chorda tympani branch of the facial nerve or the glossopharyngeal nerve, which both project from the tongue to the nucleus of the solitary tract in the brainstem.
DISCUSSION
In this report we investigated the role of the LRS in prion neuroinvasion in order to address a subset of prion diseases of livestock where infection of the LRS either is restricted or does not appear to be essential for neuroinvasion. We tested the hypothesis that prion neuroinvasion by the DY TME agent is independent of LRS infection following inoculation by several extraneural routes, including the tongue. Intraperitoneal inoculation of the DY TME agent did not result in (i) TME agent infectivity in lymph nodes or spleen, (ii) PrP Sc deposition in lymph nodes, spleen or brain, and (iii) clinical disease. In a prior study, DY TME agent infectivity was not detected in the spleen, sympathetic chain, or brain of hamsters at 80 to 405 days postinoculation of the DY TME agent by the i.p. route (3) . Based on these findings, we conclude that the DY TME agent does not replicate in the LRS.
To test whether the lack of DY TME agent replication in the LRS was due to an inability of this agent to be transported to the LRS, hamsters were directly inoculated in the submandibular lymph node. These animals did not develop clinical TME after 400 days postinoculation. The DY TME agent is the only reported prion agent that fails to replicate in the LRS following intraspecies inoculation of an immunocompetent host. Although subclinical prion infection has been described in rodents following extraneural inoculation, PrP Sc or infectivity is found in LRS tissues of these hosts. In mice the 87V scrapie agent can establish a subclinical infection for the life span of the host following i.p. inoculation, but scrapie infectivity was detected in the spleen within weeks of inoculation (9, 12) . Other studies reported subclinical RML scrapie infection of mice following oral ingestion, but scrapie infectivity was found in lymph nodes and brain in these aged mice (32) . These subclinical infections are distinct from extraneural inoculation with the DY TME agent, in which PrP Sc or DY TME agent infectivity has not been found in LRS tissues. Based on our studies we conclude that the DY TME agent can be used to investigate the routes of prion neuroinvasion that are independent of prion agent replication in the LRS.
The pathogenicity of the DY TME agent following routes of exposure that are known to be dependent on agent replication in the LRS prior to neuroinvasion were compared to inocula-
FIG. 3. PrP
Sc deposition in the hypoglossal nucleus of hamsters following intratongue inoculation of the HY TME and DY TME agents. Hamsters were inoculated by the intratongue route with the HY TME agent (B) or DY TME agent (C). Brain was collected from HY TME-and DY TME agent-infected hamsters at 4 weeks (i.e., 35% of the HY TME agent incubation period had elapsed) and 23 weeks (i.e., 60% of the DY TME agent incubation period had elapsed) postinfection, respectively, and prepared for immunohistochemistry as described in Materials and Methods. PrP Sc immunohistochemistry (red punctate signal) revealed staining in the hypoglossal nucleus that included intrasomata PrP Sc deposits in motor neurons in HY TME agent infection and neuropil PrP Sc deposits with a paucity of intrasomata staining in DY TME agent infection. Tissue was counterstained with hematoxylin (B and C). Nissl stain (A) of the hypoglossal nucleus from a mock-infected hamster illustrates somata of motor neurons. Arrowheads indicate hypoglossal motor neurons. Bar, 20 m.
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tion in the tongue, a densely innervated peripheral tissue. The tongue was chosen as a site of inoculation for several reasons: (i) it is in direct contact with the prion agent during oral ingestion; (ii) lesions on the tongue increase the susceptibility of hamsters to HY TME agent infection when the agent is directly applied to the tongue (4); (iii) infections or lesions in the oral cavity and tongue are common in ruminant species; and (iv) prion infection of the tongue has been reported in the tongue of scrapie-infected sheep (2, 11) (R. A. Bessen, unpublished data). Hamsters were susceptible to DY TME disease following intratongue, intracerebral, and intra-sciatic nerve inoculation but not following i.p., intra-lymph node, or per os inoculation. In the intratongue, intracerebral, intra-sciatic nerve, and i.p inoculation groups, DY PrP Sc was not found in lymph nodes or spleen and DY TME agent infectivity in the LRS, sympathetic chain, or brain was not detected following i.p. inoculation (3, 5) .
It is possible that intratongue inoculation, unlike i.p. inoculation, of the DY TME agent could result in replication in the LRS. This outcome is unlikely since HY PrP Sc was found in the LRS of hamsters following neural and extraneural inoculation (3-5) but there was no evidence for DY TME agent infection in the LRS following inoculation by similar routes. Based on the lack of DY TME agent infectivity and PrP Sc in LRS tissues following i.p. inoculation and the absence of DY TME agent disease following several extraneural routes of inoculation, we conclude that neuroinvasion following intratongue inoculation of the DY TME agent is not dependent on prion agent replication in the LRS. This conclusion is consistent with a previous study using transgenic mice that express PrP C under the control of the neuron-specific enolase promoter, in which these mice were susceptible to scrapie following extraneural prion agent inoculation (26) .
DY TME agent neuroinvasion via the tongue is consistent with axonal transport along cranial nerves. Detection of PrP Sc in the brainstem at 12 weeks postinfection following intratongue inoculation of the DY TME agent was at a time when DY TME agent infectivity was not detected in lymph nodes or spleen following i.p. inoculation. The initial sites of DY PrP Sc deposition in the central nervous system following intratongue inoculation were the hypoglossal nucleus and nucleus of the solitary tract. This distribution is consistent with retrograde spread of the DY TME agent within the axons of the hypoglossal nerve to the hypoglossal nucleus, and the chorda tympani branch of the facial nerve and/or glossopharyngeal nerve to the nucleus of the solitary tract in the brainstem. In order to determine the principal route of DY TME agent neuroinvasion from the tongue, additional analysis between 8 and 12 weeks postinfection is necessary to determine the initial sites(s) of entry of the DY TME agent into the brainstem.
For the HY TME agent, following initial PrP Sc deposition in the hypoglossal nucleus there was a longer delay before PrP Sc appeared in the nucleus of the solitary tract compared to the DY TME agent, suggesting that the HY TME agent spread to the nucleus of the solitary tract via fibers that originate in the nucleus of the solitary tract and terminate on the hypoglossal motor neurons (4) . This spread to the nucleus of the solitary tract across synapses is consistent with trans-synaptic spread of pseudorabies and rabies virus transneuronal tracers following intratongue inoculation (14, 33, 34 ).
Direct prion neuroinvasion from extraneural tissues has implications for BSE and atypical scrapie in which there appears to be a reduced role for the LRS in neuroinvasion. Our findings indicate that infection of peripheral tissues that are densely innervated, such as the tongue, can result in direct neuroinvasion via cranial nerves without LRS infection. The tongue is a unique tissue in that it receives dense sensory and motor innervation from four cranial nerves. In fact, the density of motor innervation of the tongue is much greater than the density of motor innervation of other muscle groups (27) . Exposure of the tongue to the prion agent during oral ingestion makes it a potential site of agent entry and neuroinvasion, especially if lesions have disrupted the mucosal epithelium (4). Although there are no epidemiological data that indicate this is a common route of prion agent entry, the tongue is a highly innervated peripheral tissue that may be a relevant site of neuroinvasion for a subset of prion diseases of livestock in which evidence for LRS infection is lacking.
